Navigation Links
Roche Scientist Recognized for Excellence in Peptide Chemistry
Date:10/7/2009

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/). Hosted by Roche Colorado, the company's peptide manufacturing facility in Boulder, RCCPS is the only global conference exclusively dedicated to peptides. For Danho, who has a world-wide reputation as a leader and innovator in the field of peptide chemistry and the application of peptide chemistry to drug discovery, this was the second prestigious award he garnered this year.

"Each year, the world's leading peptide scientists honor one of their own at RCCPS for a lifetime of outstanding achievement," said the symposium's co-chair, Ralph Di Libero. "The selection of Waleed as the 2009 Meienhofer Award recipient is particularly compelling as it speaks volumes to the central role that Roche is playing, through all stages of drug development, at demonstrating the viability of synthetic peptide therapeutics."

This theme was echoed by Danho. "There were many who doubted the viability of synthetic peptides, relegating promising medicinal compounds to the shelf. Roche kept its faith in my vision for the future of peptides and their faith is beginning to bear fruit, with many synthetic peptides now providing meaningful health benefits and many more in the pipeline."

"Of course," concluded Danho, "I accept this tribute with due respect for my colleagues in the peptide field who helped advance the science to its present place of influence in the pharmaceutical industry. That is what makes the Meienhofer Award, receiving it as I did during this premier gathering of peptide scientists, such a meaningful tribute."


'/>"/>
SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... CASTLE ROCK, Colo. , Aug. 28, 2014 /PRNewswire/ ... diagnostic company focused on obtaining FDA clearance for ... a rapid blood test for aiding in identifying children, ... who are at low risk for appendicitis, today announced ... Rodman & Renshaw 16 th Annual Global Investment ...
(Date:8/28/2014)... DIEGO , Aug. 28, 2014 Telik, ... development company that merged with MabVax Therapeutics, Inc. ... made significant progress related to the development of ... antibody was recovered using the Company,s internally developed ... the potential for multiple antibody based therapeutic and ...
(Date:8/28/2014)... DUBLIN, Ohio , Aug. 28, 2014 /PRNewswire/ ... rising competition in generics are adding pressure to ... internal resources. Company resources continue to shrink and ... complex. This has led companies to look for ... to commercialization and for keeping approved products on ...
Breaking Medicine Technology:Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 44 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4
(Date:8/29/2014)... VA (PRWEB) August 29, 2014 ... release of Clinical Trials Magnifier Weekly. , Clinical Trial ... the world every week and reports all the fresh ... FDAnews is able to extract just the information readers ... and drill down using links in the newsletter to ...
(Date:8/29/2014)... 2014 And the results are in! ... Caicos Islands, is voted a favorite with tourists and travelers ... the World in the Travelers' Choice Awards on the popular ... all across the globe pick their favorites, and the Turks ... multiple categories. , The Venetian on Grace Bay ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Recent ... have suggested that Americans today are working longer hours ... overworked and overstressed. APEC Water believes that drinking lots ... a Labor Day Sale on their most popular and ... and healthy. From now until 9/2/2014, customers can save ...
(Date:8/29/2014)... Farms, MI (PRWEB) August 29, 2014 ... structured data (relational tables) or unstructured data (document stores). ... while NoSQL products have basically managed the wide assortment ... only way to work with Big Data is with ... to solve the various aspects of all Big Data ...
(Date:8/29/2014)... Two Kelowna dentists are putting out ... a container filled with classroom materials, clinic supplies and even ... , “I don’t think words can describe ... Matson-Visscher. She and her husband, Dr. Jonathan Visscher, both partners ... part of New Reality International’s (NRI) mission to build and ...
Breaking Medicine News(10 mins):Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 3Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 4Health News:Relax this Labor Day Weekend with Great Savings on Easy-Install, Do-It-Yourself Drinking and Whole House Water Filters 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 2Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 3
... HealthDay Reporter , TUESDAY, July 19 (HealthDay News) -- ... cancer are undergoing chemotherapy may help prevent early menopause and ... July 20 issue of the Journal of the American ... hormone triptorelin when a patient is undergoing chemotherapy helped prevent ...
... , TUESDAY, July 19 (HealthDay News) -- The antidepressants ... provide no appreciable relief, and may raise the ... "The two classes of antidepressants most likely ... no more effective than placebo," the study authors said. ...
... July, 2011 The Research4Life partners today announced two ... case study competition on how HINARI, AGORA, and/or OARE ... a pediatrician from Nepal and Mr. Mulugeta Bayisa, a ... over 60 entries to the competition held in celebration ...
... Radiation Oncology (ASTRO) has named its 2011 class of ... designation at a ceremony during the Society,s 53rd Annual ... Beach Convention Center in Miami Beach, Fla. , "ASTRO ... members of the radiation oncology community and receiving this ...
... a part of its new initiative, Expanding Access to Opioid ... Europe and Central Asia (EECA), the International AIDS Society (IAS) ... in partnership with the Ukrainian Institute on Public Health Policy ... 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS ...
... HILL, N.C. Women who have breastfeeding difficulties in ... likely to suffer postpartum depression two months later compared ... women with breastfeeding difficulties should be screened for depressive ... the University of North Carolina at Chapel Hill. ...
Cached Medicine News:Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 2Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 3Health News:Two Antidepressants Given to Dementia Patients Ineffective: Study 2Health News:Joint winners announced in Research4life global case study competition 2Health News:Joint winners announced in Research4life global case study competition 3Health News:ASTRO announces 2011 Fellows class 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 3Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 4Health News:Mothers with breastfeeding difficulties more likely to suffer postpartum depression 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: